JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.3B |
| 2 |
McDonald's
MCD
|
+$2.2B |
| 3 |
Microsoft
MSFT
|
+$2.07B |
| 4 |
NVIDIA
NVDA
|
+$1.94B |
| 5 |
Goldman Sachs
GS
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.77B |
| 2 |
Broadcom
AVGO
|
+$1.88B |
| 3 |
TSMC
TSM
|
+$1.18B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.14B |
| 5 |
Danaher
DHR
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.59% |
| 2 | Healthcare | 9.24% |
| 3 | Consumer Discretionary | 9.21% |
| 4 | Financials | 9.1% |
| 5 | Industrials | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
Vestis
VSTS
$1.76B
| $1.99M | ﹤0.01% |
133,579
-87,143
| -39% | -$1.17M |
|
|
SEI
3852
Solaris Energy Infrastructure
SEI
$4.17B
| $1.99M | ﹤0.01% |
155,705
+18,613
| +14% | +$222K |
|
3853
Castle Biosciences
CSTL
$905M
| $1.98M | ﹤0.01% |
69,409
+43,241
| +165% | +$1.1M |
|
|
ITCI
3854
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.98M | ﹤0.01% |
27,000
-30,300
| -53% | -$2.28M |
|
|
ITCI
3855
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.98M | ﹤0.01% |
27,000
| – | – |
|
|
ENFN
3856
DELISTED
Enfusion, Inc.
ENFN
| $1.97M | ﹤0.01% |
208,022
+178,821
| +612% | +$1.54M |
|
3857
Dave Inc
DAVE
$4.27B
| $1.96M | ﹤0.01% |
49,168
+37,571
| +324% | +$1.36M |
|
3858
PUT
DraftKings
DKNG
$13B
| $1.96M | ﹤0.01% |
+50,000
| New | +$1.81M |
|
3859
PUT
Planet Fitness
PLNT
$3.8B
| $1.96M | ﹤0.01% |
+24,100
| New | +$1.89M |
|
3860
Schneider National
SNDR
$6.33B
| $1.95M | ﹤0.01% |
68,485
-6,681
| -9% | -$177K |
|
|
BSJO
3861
DELISTED
Invesco BulletShares 2024 High Yield Corporate Bond ETF
BSJO
| $1.95M | ﹤0.01% |
85,928
+18,526
| +27% | +$421K |
|
3862
uniQure
QURE
$3.37B
| $1.95M | ﹤0.01% |
395,538
-270,042
| -41% | -$1.76M |
|
3863
Invesco China Technology ETF
CQQQ
$3.18B
| $1.95M | ﹤0.01% |
47,205
-17,067
| -27% | -$563K |
|
3864
Heritage Insurance Holdings
HRTG
$1.01B
| $1.95M | ﹤0.01% |
159,005
+149,172
| +1,517% | +$1.73M |
|
3865
CALL
Nutrien
NTR
$32.6B
| $1.94M | ﹤0.01% |
40,400
| – | – |
|
|
LAND
3866
Gladstone Land Corp
LAND
$358M
| $1.94M | ﹤0.01% |
139,298
+53,400
| +62% | +$752K |
|
3867
CALL
Travel + Leisure Co
TNL
$4.63B
| $1.94M | ﹤0.01% |
+42,000
| New | +$1.86M |
|
|
MRX
3868
Marex Group Limited Ordinary Shares
MRX
$5.11B
| $1.93M | ﹤0.01% |
81,797
+77,281
| +1,711% | +$1.72M |
|
|
LGF.B
3869
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $1.93M | ﹤0.01% |
279,093
-1,021,082
| -79% | -$7.67M |
|
3870
iShares iBonds Dec 2033 Term Corporate ETF
IBDY
$1.09B
| $1.93M | ﹤0.01% |
+73,124
| New | +$1.89M |
|
3871
NuScale Power
SMR
$3.85B
| $1.93M | ﹤0.01% |
166,629
+111,812
| +204% | +$1.14M |
|
3872
PUT
The GEO Group
GEO
$4.11B
| $1.93M | ﹤0.01% |
+150,000
| New | +$2.09M |
|
|
ARI
3873
Apollo Commercial Real Estate
ARI
$876M
| $1.92M | ﹤0.01% |
208,944
-93,116
| -31% | -$949K |
|
3874
CALL
Cameco
CCJ
$42.6B
| $1.92M | ﹤0.01% |
+40,200
| New | +$1.75M |
|
3875
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.98B
| $1.92M | ﹤0.01% |
45,833
-10,747
| -19% | -$432K |
|
Similar funds
JP Morgan Chase's Q3 2024 Portfolio in Review
As of Q3 2024, JP Morgan Chase held 7,854 positions worth $1.32T, up 7.9% from $1.22T the previous quarter. Its ten largest holdings account for 23% of the portfolio.
JP Morgan Chase's Q3 2024 filing shows 533 new, 3,476 increased, 2,341 reduced and 444 closed positions. Its largest new stake was Smurfit Westrock: 4,472,396 shares worth $221M. The largest sale was Advanced Micro Devices, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- JP Morgan Chase's largest Q3 2024 buy was Smurfit Westrock: 4,472,396 shares worth $221M.
- JP Morgan Chase added most to iShares Broad USD High Yield Corporate Bond ETF in Q3 2024, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q3 2024 reduction was Advanced Micro Devices, cutting an estimated $2.77B.
- JP Morgan Chase fully exited WestRock Company in Q3 2024, selling an estimated $320M.
- JP Morgan Chase's ten largest holdings make up 23% of its $1.32T portfolio in Q3 2024.
- JP Morgan Chase opened 533 new positions and closed 444 in Q3 2024.
- JP Morgan Chase's portfolio value rose 7.9% quarter-over-quarter to $1.32T.
Based on JP Morgan Chase's 13F filing for Q3 2024, filed 8 Nov 2024.